We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Classifies Seryx's Software as an Unapproved Device
FDA Classifies Seryx's Software as an Unapproved Device
April 13, 2007
Saying Seryx’s software is classified as a medical device, the FDA cited the firm in a recent warning letter for marketing its Signature Genetics program without first obtaining agency approval.